About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Chemotherapy for Patients With Non-Small Cell Lung Cancer

Chemotherapy for Patients With Non-Small Cell Lung Cancer

NCT00380718·2 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Eli Lilly and Company

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Histologic or cytologic diagnosis non-small cell lung cancer (NSCLC) (Stage IIIB or IV)
Patients' NSCLC must have progressed following one chemotherapy regimen for palliative therapy with or without subsequent targeted biological therapy
Disease status must be that of measureable disease as defined by Response Evaluation Criteria In Solid Tumors (RECIST) criteria
Eastern Cooperative Oncology Group (ECOG) performance status 0 to 1

You may not be if

Concurrent administration of any other tumor therapy
Pregnancy or breast feeding
Serious concomitant disorders
Inability or unwillingness to take folic acid or vitamin B12 supplementation

The record

StatusCompleted

PhasePhase 4

Taking part33

StartedNov 2006

UpdatedNov 16, 2010

Conditions

Non-small Cell Lung Cancer

Where2

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Taichung, Taiwan
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Taipei, Taiwan